HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ulrike Schmidt Selected Research

Anorexia Nervosa

6/2022An exploratory examination of executive functioning as an outcome, moderator, and predictor in outpatient treatment for adults with anorexia nervosa.
1/2022'My dad was like "it's your brain, what are you doing?"': Participant experiences of repetitive transcranial magnetic stimulation treatment in severe enduring anorexia nervosa.
1/2022Short communication: Serum levels of brain-derived neurotrophic factor and association with pro-inflammatory cytokines in acute and recovered anorexia nervosa.
1/2022Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in female outpatients with anorexia nervosa (ANTOP study): 5-year follow-up of a randomised controlled trial in Germany.
8/2021Reduced MIP-1β as a Trait Marker and Reduced IL-7 and IL-12 as State Markers of Anorexia Nervosa.
7/2021A pilot study exploring the effect of repetitive transcranial magnetic stimulation (rTMS) treatment on cerebral blood flow and its relation to clinical outcomes in severe enduring anorexia nervosa.
6/2021The Maudsley Anorexia Nervosa Treatment for Adults (MANTRA): a feasibility case series of an integrated group based approach.
1/2021A preliminary exploration of the effect of concurrent antidepressant medication on responses to high-frequency repetitive transcranial magnetic stimulation (rTMS) in severe, enduring anorexia nervosa.
1/2021Outpatient therapy for adult anorexia nervosa: Early weight gain trajectories and outcome.
1/2021Cytokines and Water Distribution in Anorexia Nervosa.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ulrike Schmidt Research Topics

Disease

43Anorexia Nervosa
06/2022 - 06/2010
27Feeding and Eating Disorders (Eating Disorder)
01/2022 - 04/2010
22Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
11/2021 - 05/2011
10Mental Disorders (Mental Disorder)
10/2021 - 01/2013
7Schizophrenia (Dementia Praecox)
01/2021 - 01/2013
6Wounds and Injuries (Trauma)
12/2019 - 05/2011
6Bulimia Nervosa
11/2019 - 10/2004
5Neoplasms (Cancer)
02/2021 - 10/2003
4Bulimia (Binge Eating)
01/2022 - 04/2010
4Binge-Eating Disorder (Binge Eating Disorder)
11/2021 - 08/2015
3Weight Gain
01/2021 - 01/2018
3Body Weight (Weight, Body)
01/2018 - 11/2013
3Hepatocellular Carcinoma (Hepatoma)
05/2007 - 09/2005
2Obesity
03/2021 - 11/2017
2Neoplasm Metastasis (Metastasis)
02/2021 - 09/2014
2Psychotic Disorders (Schizoaffective Disorder)
03/2020 - 01/2018
2Starvation
01/2017 - 01/2010
2Anxiety Disorders (Anxiety Disorder)
01/2015 - 01/2013
1COVID-19
02/2022
1Neuroinflammatory Diseases
09/2021
1Carcinoma (Carcinomatosis)
02/2021
1Lung Neoplasms (Lung Cancer)
02/2021
1Colorectal Neoplasms (Colorectal Cancer)
02/2021
1Body-Weight Trajectory
01/2021
1Emaciation
01/2020
1Overweight
10/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2019
1Panic Disorder (Panic Attack)
10/2018
1Infections
01/2018
1Bacterial Infections (Bacterial Infection)
01/2018

Drug/Important Bio-Agent (IBA)

9salicylhydroxamic acid (SHAM)IBA
01/2022 - 04/2010
7Proteins (Proteins, Gene)FDA Link
11/2021 - 09/2005
7Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2013
6CytokinesIBA
01/2022 - 09/2014
5Pharmaceutical PreparationsIBA
01/2018 - 01/2015
4Messenger RNA (mRNA)IBA
10/2021 - 10/2018
4NeuropeptidesIBA
01/2021 - 05/2012
4Antipsychotic Agents (Antipsychotics)IBA
01/2021 - 07/2013
3Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022 - 01/2021
3Tacrolimus Binding Proteins (FKBP)IBA
11/2021 - 01/2015
3InterleukinsIBA
10/2021 - 09/2014
3LipidsIBA
01/2019 - 07/2013
3Biological ProductsIBA
01/2019 - 05/2015
3Cytosine DeaminaseIBA
05/2007 - 09/2005
3ProdrugsIBA
05/2007 - 09/2005
3Flucytosine (Ancobon)FDA Link
05/2007 - 09/2005
2Dexamethasone (Maxidex)FDA LinkGeneric
10/2021 - 01/2019
2Antidepressive Agents (Antidepressants)IBA
01/2021 - 01/2013
2Hydrocortisone (Cortisol)FDA LinkGeneric
01/2019 - 11/2016
2Dopamine (Intropin)FDA LinkGeneric
01/2016 - 01/2016
2mesoglycanIBA
06/2015 - 01/2015
2MicroRNAs (MicroRNA)IBA
06/2015 - 01/2013
2Fluoxetine (Prozac)FDA LinkGeneric
01/2013 - 01/2012
2DNA (Deoxyribonucleic Acid)IBA
05/2012 - 10/2003
2EnzymesIBA
11/2005 - 09/2005
1tacrolimus binding protein 4 (FKBP52)IBA
11/2021
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
10/2021
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2021
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
10/2021
1Type I Tumor Necrosis Factor ReceptorsIBA
10/2021
1Interleukin-12 (IL 12)IBA
08/2021
1Interleukin-7 (Interleukin 7)IBA
08/2021
1Small Interfering RNA (siRNA)IBA
02/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2021
1Matrix Metalloproteinases (MMPs)IBA
02/2021
1Cadherins (E-Cadherin)IBA
02/2021
1Oxytocin Receptors (Oxytocin Receptor)IBA
01/2021
1Oxytocin (Pitocin)FDA LinkGeneric
01/2021
1ElectrolytesIBA
05/2020
1PhytohemagglutininsIBA
11/2019
1InterferonsIBA
11/2019
1Melanocyte-Stimulating Hormones (MSH)IBA
01/2019
1Blood Glucose (Blood Sugar)IBA
01/2019
1MelanocortinsIBA
01/2019
1Pro-Opiomelanocortin (Proopiomelanocortin)IBA
01/2019
1Arachidonic Acid (Vitamin F)IBA
01/2018
1Serotonin (5 Hydroxytryptamine)IBA
01/2018
1Niacin (Nicotinic Acid)FDA LinkGeneric
01/2018
1methyl nicotinateIBA
01/2018
1Polytetrafluoroethylene (Teflon)FDA Link
01/2018
1ProstaglandinsIBA
01/2018
1ORALIT (ORS)IBA
01/2018
1Olanzapine (Zyprexa)FDA Link
01/2017
1phosphorylethanolamine (phosphoethanolamine)IBA
01/2017
1GlycosphingolipidsIBA
01/2017

Therapy/Procedure

24Therapeutics
06/2022 - 11/2005
15Transcranial Magnetic Stimulation
01/2022 - 04/2010
9Transcranial Direct Current Stimulation
11/2021 - 11/2013
4Deep Brain Stimulation
06/2021 - 11/2013
4Ambulatory Care (Outpatient Care)
11/2020 - 07/2014
3Secondary Prevention
01/2019 - 07/2013
2Caloric Restriction
03/2021 - 01/2020
2Drug Therapy (Chemotherapy)
01/2018 - 10/2004
2Neurofeedback
11/2017 - 11/2013
1Patient Isolation
02/2022
1Aftercare (After-Treatment)
07/2020
1Cognitive Training
10/2019
1Precision Medicine
01/2018
1Length of Stay
01/2018
1Transitional Care
11/2017